These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22467671)

  • 1. Editorial commentary: Asking the right questions: morbidity, mortality, and measuring what's important in unbiased evaluations of antimicrobials.
    Powers JH
    Clin Infect Dis; 2012 Jun; 54(12):1710-3. PubMed ID: 22467671
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute necrotizing pancreatitis related to tigecycline.
    Mascarello M; Papa G; Arnez ZM; Luzzati R
    J Antimicrob Chemother; 2012 May; 67(5):1296-7. PubMed ID: 22279181
    [No Abstract]   [Full Text] [Related]  

  • 3. Tigecycline: a single antibiotic for polymicrobial infections.
    Pankey GA; Steele RW
    Pediatr Infect Dis J; 2007 Jan; 26(1):77-8. PubMed ID: 17195711
    [No Abstract]   [Full Text] [Related]  

  • 4. More about the safety of tigecycline for the treatment of infectious diseases: the role of superinfection rates.
    Martín-Gandul C; García-Cabrera E; Castillo-Ojeda E; Jiménez-Mejías ME
    J Antimicrob Chemother; 2012 Apr; 67(4):1048-9. PubMed ID: 22207597
    [No Abstract]   [Full Text] [Related]  

  • 5. Extreme alkaline phosphatase elevation associated with tigecycline.
    Bonilla MF; Avery RK; Rehm SJ; Neuner EA; Isada CM; van Duin D
    J Antimicrob Chemother; 2011 Apr; 66(4):952-3. PubMed ID: 21393193
    [No Abstract]   [Full Text] [Related]  

  • 6. High-dose tigecycline-associated alterations in coagulation parameters in critically ill patients with severe infections.
    Routsi C; Kokkoris S; Douka E; Ekonomidou F; Karaiskos I; Giamarellou H
    Int J Antimicrob Agents; 2015 Jan; 45(1):90-3. PubMed ID: 25241261
    [No Abstract]   [Full Text] [Related]  

  • 7. True incidence of tigecycline-induced pancreatitis: how many cases are we missing?
    Davido B; Shourick J; Makhloufi S; Dinh A; Salomon J
    J Antimicrob Chemother; 2016 Oct; 71(10):2994-5. PubMed ID: 27365188
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics, pharmacodynamics, safety and tolerability of tigecycline.
    Rello J
    J Chemother; 2005 Aug; 17 Suppl 1():12-22. PubMed ID: 16285354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Stenotrophomonas maltophilia and tigecycline in clinical practice].
    Conde-Estévez D; Grau S; Alvarez-Lerma F
    Enferm Infecc Microbiol Clin; 2012 Mar; 30(3):170-1. PubMed ID: 22277371
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness and Safety of Tigecycline Compared with Other Broad-Spectrum Antimicrobials in Abdominal Solid Organ Transplant Recipients with Polymicrobial Intraabdominal Infections.
    Liebenstein T; Schulz LT; Viesselmann C; Bingen E; Musuuza J; Safdar N; Rose WE
    Pharmacotherapy; 2017 Feb; 37(2):151-158. PubMed ID: 27983753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline: place in therapy and important considerations.
    Garrelts JC; Schroeder T
    Am J Health Syst Pharm; 2006 Jul; 63(13):1233. PubMed ID: 16790574
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA limits acetaminophen; risk of death with tigecycline.
    DeDea L
    JAAPA; 2012 Sep; 25(9):16. PubMed ID: 22991880
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tigecycline--a new antibiotic].
    Skibeli V; Aaløkken I; Lingaas E; Midtvedt T; Solberg CO; Melby KK
    Tidsskr Nor Laegeforen; 2010 Aug; 130(16):1624-6. PubMed ID: 20805861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline in the management of osteomyelitis: a case series from the bone and joint infection (BAJIO) database.
    Griffin AT; Harting JA; Christensen DM
    Diagn Microbiol Infect Dis; 2013 Nov; 77(3):273-7. PubMed ID: 24029432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tigecycline and overall mortality.
    Yahav D; Lador A; Paul M; Leibovici L
    Clin Infect Dis; 2012 Dec; 55(12):1739. PubMed ID: 22972870
    [No Abstract]   [Full Text] [Related]  

  • 16. Excess deaths associated with tigecycline after approval based on noninferiority trials.
    Prasad P; Sun J; Danner RL; Natanson C
    Clin Infect Dis; 2012 Jun; 54(12):1699-709. PubMed ID: 22467668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishing the role of tigecycline in an era of antimicrobial resistance.
    Schafer JJ; Goff DA
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
    Ni W; Li G; Zhao J; Cui J; Wang R; Gao Z; Liu Y
    Infect Dis (Lond); 2018 Jul; 50(7):507-513. PubMed ID: 29316830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of tigecycline trials announced.
    McConnell J
    Lancet Infect Dis; 2004 Dec; 4(12):717. PubMed ID: 15593443
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of tigecycline.
    Falagas ME; Karageorgopoulos DE; Dimopoulos G
    Curr Drug Metab; 2009 Jan; 10(1):13-21. PubMed ID: 19149509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.